| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.0M | -24.8% |
| SG&A Expense | $6.5M | +0.3% |
| Operating Income | -$13.2M | +7.6% |
| Income Tax | $0 | — |
| Net Income | -$12.6M | +2.8% |
| EPS (Basic) | -$1.93 | +17.9% |
| EPS (Diluted) | -$1.93 | +21.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.6M | -36.1% |
| Current Assets | $15.6M | -34.0% |
| Total Assets | $15.9M | -33.6% |
| Current Liabilities | $2.8M | -17.8% |
| Stockholders' Equity | $12.4M | -35.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.9M | +4.9% |
| Capital Expenditures | $15K | +0.0% |
| Investing Cash Flow | -$15K | +0.0% |
| Financing Cash Flow | $4.6M | -68.7% |
| Free Cash Flow | -$12.9M | +4.9% |